
|Articles|February 15, 2007
Sodium hyaluronate compound studied
Chapel Hill, NC-Lantibio Inc. and TRB Chemedica have begun a phase III clinical trial with VISMED, a patented formulation containing sodium hyaluronate, to treat dry eye syndrome.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement


















